Koers Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi
Aandelen
MEDTR
TREMDTR00028
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
31,98 TRY | -1,54% | -4,48% | +14,87% |
Omzet 2022 | 806 mln. 24,88 mln. 23,06 mln. | Omzet 2023 | 1,45 mld. 44,82 mln. 41,55 mln. | Marktkapitalisatie | 3,31 mld. 102 mln. 94,79 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 297 mln. 9,17 mln. 8,5 mln. | Nettowinst (verlies) 2023 | 25 mln. 772K 715K | EV/omzet 2022 | 5,52 x |
Nettoliquiditeiten 2022 | 312 mln. 9,64 mln. 8,94 mln. | Nettoliquiditeiten 2023 | 339 mln. 10,45 mln. 9,69 mln. | EV/omzet 2023 | 2,05 x |
K/w-verhouding 2022 |
16
x | K/w-verhouding 2023 |
128
x | Werknemers | 728 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 20,55% |
1 dag | -1,54% | ||
1 week | -4,48% | ||
Lopende maand | -3,03% | ||
1 maand | +5,68% | ||
3 maanden | +1,20% | ||
6 maanden | -18,21% | ||
Lopend jaar | +14,87% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hicret Yanik
DFI | Director of Finance/CFO | - | - |
Gülperi Ölmez
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 12-04-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Adnan Yildirim
BRD | Director/Board Member | 64 | 12-04-21 |
Atilla Sevinçli
CHM | Chairman | - | 12-04-21 |
Mert Sevinçli
BRD | Director/Board Member | - | 12-04-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 31,98 | -1,54% | 435 218 |
25-04-24 | 32,48 | -1,58% | 435 067 |
24-04-24 | 33 | -1,96% | 512 478 |
22-04-24 | 33,66 | +0,54% | 639 090 |
19-04-24 | 33,48 | +1,70% | 507 537 |
uitgestelde koers Borsa Istanbul, 26 april 2024 om 17:09 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+14,87% | 117 mln. | |
+73,17% | 12,38 mld. | |
-18,74% | 7,92 mld. | |
+16,15% | 7,2 mld. | |
+4,81% | 5,84 mld. | |
+5,99% | 5,01 mld. | |
+27,07% | 4,53 mld. | |
-21,67% | 3,88 mld. | |
-40,82% | 2,23 mld. | |
+1,49% | 2,02 mld. |